Nogo-A exacerbates sepsis-associated encephalopathy by modulating microglial SHP-2/NLRP3 balance and inducing ROS and M1 polarization
2024

Nogo-A's Role in Sepsis-Associated Encephalopathy

Sample size: 21 publication 10 minutes Evidence: moderate

Author Information

Author(s): Liu Ying, Guo Lei, Zhang Guoan, Sun Wenjie, Yang Xiaohui, Liu Yingfu

Primary Institution: Cangzhou Medical College

Hypothesis

Nogo-A exacerbates sepsis-associated encephalopathy by modulating microglial SHP-2/NLRP3 balance and inducing ROS and M1 polarization.

Conclusion

Nogo-A significantly affects mitochondrial autophagy and neuronal survival by inhibiting SHP2 and activating ROS, contributing to neuroinflammation in sepsis-associated encephalopathy.

Supporting Evidence

  • Nogo-A expression affects learning and memory in septic mice.
  • Knockdown of Nogo-A reduces neuronal damage.
  • Bioinformatics analysis suggests Nogo-A activates ROS to inhibit p-SHP2.
  • Western blot results confirm Nogo-A's effects on mitochondrial autophagy and neuronal survival.

Takeaway

Nogo-A is a protein that can make brain problems worse during sepsis, but if we reduce its activity, it can help protect the brain.

Methodology

The study used in vivo and in vitro methods, including mouse models and BV-2 microglial cells, to investigate the effects of Nogo-A on neuroinflammation and neuronal damage.

Potential Biases

Potential off-target effects from gene knockout techniques.

Limitations

The study's models may not fully replicate human conditions, and gene knockout technology may have off-target effects.

Participant Demographics

Healthy SPF-grade C57BL/6J male mice, aged 6-8 weeks.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.17305/bb.2024.10822

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication